Our goal is to progress the clinical development of our discoveries,
substantially increase their values, and to ultimately market or out-license.
NASH : Non-alcoholic fatty liver disease, AMD : Age-related macular degeneration, RA : Rheumatoid arthritis,
IBD : inflammatory bowel disease
